End-of-day quote
Other stock markets
|
||
- USD | - |
Chart calendar Theravance Inc
Upcoming events on Theravance Inc
Past events on Theravance Inc
2024-02-29 04:05 pm | Q4 2023 Earnings Release |
2023-11-01 04:15 pm | Q3 2023 Earnings Release |
2023-10-14 12:15 pm | IDWeek Conference - Poster No:2517 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No:2515 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No:2526 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No:2121 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No:2133 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No:2132 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No:2138 |
2023-10-14 12:15 pm | IDWeek Conference - Poster No:2549 |
2023-10-12 10:30 am | IDWeek Conference |
2023-09-27 01:50 pm | Cantor Global Healthcare Conference |
2023-08-02 04:05 pm | Q2 2023 Earnings Release |
2023-06-12 05:00 pm | Goldman Sachs Global Healthcare Conference |
2023-05-22 11:00 am | Annual General Meeting |
2023-05-09 04:32 pm | Q1 2023 Earnings Release |
2023-02-28 04:10 pm | Q4 2022 Earnings Release |
2022-11-09 04:05 pm | Q3 2022 Earnings Release |
2022-10-19 | Infectious Disease Society of America Meeting |
2022-09-14 11:10 am | Morgan Stanley Global Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 261 257 1.38% | 337 261 29.25% | 392 292 34.12% | 331 338 -1.83% | 310 300 3.44% | 301 |
EBITDA Million USD | Released Forecast Spread | 260 255 2.13% | 335 246 36.13% | 389 274 42.09% | 221 229 -3.42% | 0,00 144 - | 115 |
EBIT Million USD | Released Forecast Spread | 246 242 1.9% | 321 245 31.1% | 375 273 37.64% | 207 218 -5.11% | 136 116 17.25% | 95,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 233 229 1.7% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | 157 156 0.83% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EPS USD | Released Forecast Spread | 1,43 1,38 3.62% | 0,00 0,00 - | 0,00 0,00 - | 2,37 0,85 178.82% | 0,00 0,00 - | 0,00 |
Announcement Date | 05/02/20 | 03/02/21 | 09/02/22 | 28/02/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 90,1 86,4 4.23% | 108 215 -49.61% | 67,3 200 -66.45% | 65,8 58,9 11.81% | 76,4 62,0 23.16% | 81,0 67,9 19.25% | 67,3 75,7 -11.1% | 85,8 75,5 13.67% | 68,0 | 75,8 | 73,1 | 83,8 |
EBITDA Million USD | Released Forecast Spread | 86,1 47,5 81.36% | 27,9 37,8 -26.07% | 25,6 39,7 -35.5% | 38,8 35,9 8.01% | ||||||||
EBIT Million USD | Released Forecast Spread | 82,6 325 -74.61% | 22,5 173 -87.01% | 24,2 21,0 14.96% | 29,9 23,9 25.12% | 33,5 22,8 46.61% | 17,9 24,7 -27.44% | 44,0 24,1 82.93% | 20,6 | 25,6 | 19,3 | 30,2 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 286 34,9 720.7% | 41,1 23,3 76.57% | ||||||||||
Net income Million USD | Released Forecast Spread | 266 27,0 883.42% | 34,9 19,4 79.72% | ||||||||||
EPS USD | Released Forecast Spread | 2,80 0,31 803.23% | -0,98 0,29 -437.93% | 0,42 0,23 82.61% | |||||||||
Announcement Date | 27/04/22 | 27/07/22 | 09/11/22 | 28/02/23 | 09/05/23 | 02/08/23 | 01/11/23 | 29/02/24 | - | - | - | - |
Past sector events for Theravance Inc
- Stock Market
- Equities
- INVA Stock
- Stock
- Calendar Theravance Inc